Patient-Reported Outcomes of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Dougados, Maxime [1 ]
Tsai, Wen-Chan [2 ]
Saaibi, Diego Luis [3 ]
Bonin, Randi [4 ]
Bukowski, Jack [4 ]
Pedersen, Ronald [4 ]
Vlahos, Bonnie [4 ]
Kotak, Sameer [5 ]
机构：
[1] Paris Descartes Univ, APHP, Cochin Hosp, Paris, France
[2] Chung Ho Mem Hosp, Kaohsiung 807, Taiwan
[3] MEDICITY SAS, Santander 681001, Colombia
[4] Pfizer Inc, Collegeville, PA USA
[5] Pfizer Inc, New York, NY USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1546
引用
收藏
页码：S656 / S657
页数：2
相关论文
共 50 条
  • [1] CLINICAL AND IMAGING EFFICACY OF ETANERCEPT IN EARLY NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Dougados, M.
    van der Heijde, D.
    Sieper, J.
    Braun, J.
    Maksymowych, W. P.
    Citera, G.
    Pedersen, R.
    Bonin, R.
    Bukowski, J.
    Koenig, A. S.
    Vlahos, B.
    Alvarez, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 87 - 88
  • [2] Safety and Efficacy Of Etanercept In Early Non-Radiographic Axial Spondyloarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial At 24 Weeks
    Dougados, Maxime
    van der Heijde, Desiree
    Sieper, Joachim
    Braun, Juegen
    Maksymowych, Walter P.
    Citera, Gustavo
    Wei, James Cheng-Chung
    Lenaerts, Jan
    Pedersen, Ronald
    Bonin, Randi
    Mahgoub, Ehab Y.
    Vlahos, Bonnie
    Bukowski, Jack
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S642 - S643
  • [3] QUALITY OF LIFE WITH ETANERCEPT IN EARLY NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24 AND 48-WEEK DATA FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Sieper, J.
    Drescher, E.
    Rosa, J.
    Pedersen, R.
    Bonin, R.
    Vlahos, B.
    Bukowski, J.
    Kotak, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 719 - 719
  • [4] Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis
    Maksymowych, Walter P.
    Wichuk, Stephanie
    Dougados, Maxime
    Jones, Heather E.
    Pedersen, Ron
    Szumski, Annette
    Marshall, Lisa
    Bukowski, Jack F.
    Lambert, Robert G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (01) : 78 - 84
  • [5] RAPID IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK RESULTS OF A PHASE 3 DOUBLE BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Coteur, G.
    Woltering, F.
    Landewe, R.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A227 - A227
  • [6] A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
    Burgos-Vargas, Ruben
    Loyola-Sanchez, Adalberto
    Ramiro, Sofia
    Reding-Bernal, Arturo
    Alvarez-Hernandez, Everardo
    van der Heijde, Desiree
    Vazquez-Mellado, Janitzia
    [J]. ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [7] A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
    Rubén Burgos-Vargas
    Adalberto Loyola-Sanchez
    Sofia Ramiro
    Arturo Reding-Bernal
    Everardo Alvarez-Hernandez
    Desirée van der Heijde
    Janitzia Vázquez-Mellado
    [J]. Arthritis Research & Therapy, 24
  • [8] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Deodhar, A.
    Van den Bosch, F.
    Poddubnyy, D.
    Maksymowych, W. P.
    Van der Heijde, D.
    Kim, T. H.
    Kishimoto, M.
    Duan, Y.
    Li, Y.
    Pangan, A.
    Wung, P.
    Song, I. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 9 - 10
  • [9] Rapid Improvements in Patient Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis: 24 Week Results of a Phase 3 Double Blind Randomized Placebo-Controlled Study.
    Sieper, Joachim
    Kivitz, Alan J.
    Van Tubergen, A. M.
    Deodhar, Atul A.
    Coteur, Geoffroy
    Woltering, Franz
    Landewe, Robert B. M.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S243 - S243
  • [10] Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial
    Van den Bosch, Filip
    Deodhar, Atul
    Poddubnyy, Denis
    Maksymowych, Walter P.
    van der Heijde, Desiree
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Baraliakos, Xenofon
    Li, Yihan
    D'Silva, Kristin
    Wung, Peter
    Song, In-Ho
    [J]. ACR OPEN RHEUMATOLOGY, 2024, 6 (08) : 470 - 480
12345